-
10/23/24 Health Advisory: Presumed positive human cases of avian influenza in Washington.
Washington State Department of Health is investigating presumed positive human cases of avian influenza in Washington. Healthcare providers should consider avian influenza in patients who present with acute respiratory illness, isolated conjunctivitis, or influenza-like illness (ILI). Assess patients for exposure to animals––especially poultry, cattle, and wildlife, or to people suspected or known to be infected. Current…
-
10/17/24 Health Advisory: Disruptions in Availability of Peritoneal Dialysis and Intravenous Solutions from Baxter International Facility in North Carolina
BackgroundOver several days in late September 2024, Hurricane Helene caused extensive damage to the southeastern United States. The storm affected the Baxter International’s North Cove facility in North Carolina, the largest manufacturer of peritoneal dialysis and intravenous solutions in the United States, halting production. Additional supply disruption may occur in the aftermath of Hurricane Milton. Recommendations for Healthcare…
-
09/23/24 Health Advisory: 2024–2025 Respiratory Illness Season Vaccine Recommendations
Summary COVID-19 vaccine recommendations For most people, the minimum interval between their last 2023–2024 COVID-19 vaccine dose and their 2024–2025 COVID-19 vaccine dose is 8 weeks. There are exceptions for people completing a multidose initial vaccination series, including: Learn more in CDC’s detailed vaccination schedules for people who are not moderately or severely immunocompromised and people who are…
-
04/30/24 Health Advisory: Invasive Serogroup Y Meningococcal Disease Increasing in the United States
Summary Invasive serogroup Y meningococcal disease cases are on the rise in the United States. Cases are disproportionately occurring in people who are: 30–60 years old. Black or African American. Living with HIV. Washington has not seen an increase in cases. Patients with invasive meningococcal disease may have bloodstream infection or septic arthritis, without typical meningitis symptoms…
-
03/27/2024 Health Advisory: Measles Increasing in Washington, the Nation, and the World
Summary Background Measles is a highly contagious viral illness that can lead to severe health complications, like pneumonia, encephalitis, and death, especially in unvaccinated people. Measles outbreaks have occurred in Washington, the United States, and around the world in 2024. Outbreaks often start when an unvaccinated or under-vaccinated person is exposed during international travel and…
-
02/08/24 Health Advisory: RSV Prevention Updates
Summary Background On Oct. 23, 2023, Centers for Disease Control and Prevention (CDC) issued a health alert about the limited supply of nirsevimab. CDC recommended healthcare providers prioritize nirsevimab for infants born later in RSV (respiratory syncytial virus) season or for those at increased risk for severe illness. On Jan. 5, 2024, CDC issued updated guidance about the increased…
-
01/22/24 Health Advisory: Measles Outbreak in Southwest Washington
An active measles outbreak investigation is underway in Clark and Wahkiakum Counties. As of Jan. 10, 2024, investigators have identified 3 lab-confirmed and 3 epidemiologically linked measles cases in unvaccinated adults. Symptoms began in mid-to-late December. All report isolating at home during their contagious period. Investigators have not identified any public exposure locations. Healthcare providers…
-
12/13/23 Health Advisory: Test for tuberculosis people who were incarcerated
A large outbreak of tuberculosis (TB) in the state prison system may affect more than 800 people who were incarcerated. Requested actions Ask patients about risk factors for TB exposure: Test people with risk factors unless they have a known history of TB infection or TB disease. Evaluate people who test positive to rule out…
-
12/07/23 Health Advisory: Test perinatally exposed children for hepatitis C.
Action requested Centers for Disease Control and Prevention (CDC) recommends you test children born to people with: Test children for HCV RNA at 2–6 months old, up to 17 months old. Give untested children older than 18 months an HCV antibody test with reflex to HCV RNA. Report hepatitis C cases in pregnant people and the…
-
11/22/23 Health Advisory: Nirsevimab supplies are short.
Advisory or Update, Communicable Disease and Immunization Update, Health Advisory, Provider Resources, VaccineNirsevimab (Beyfortus) RSV preventive antibodies for infants is in short supply. Encourage Abrysvo vaccine for pregnant people to protect babies from RSV. Washington will receive 7,700 50 mg and 600 100 mg nirsevimab doses for the remainder of respiratory syncytial virus (RSV) season. Centers for Disease Control and Prevention (CDC) released a Health Alert that…
-
Health Officer recommends masking in patient and visitor contact areas of healthcare settings
Advisory or Update, Communicable Disease and Immunization Update, Communicable Disease Data Report, COVID-19, Health Advisory, Health Alert, UncategorizedMonitoring of ED visits due to RSV disease indicates that our region has exceeded the threshold for seasonal rapid increase in cases. We also expect to see a rapid increase in influenza visits in the coming weeks, and COVID-19 is still spreading in the community. To reduce the risk of viral pathogen transmission in healthcare…
-
10/02/23 Health Advisory: 2023–2024 Respiratory Illness Season
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, News and Alerts, News and Update, Notifiable Conditions, Provider ResourcesThis 2023–2024 respiratory illness season, we’re monitoring 3 common causes of respiratory illness that circulate in Island County: influenza, respiratory syncytial virus (RSV), and COVID-19. Please review the information below and resources posted on the Island County Public Health Seasonal Respiratory Illnesses webpage. Influenza Centers for Disease Control and Prevention (CDC) estimates that in the…
-
09/20/23 Health Advisory: New COVID-19 Vaccines Authorized, Previous Bivalent COVID-19 Vaccines Deauthorized
Advisory or Update, Communicable Disease and Immunization Update, COVID-19, Health Advisory, News and Alerts, Provider ResourcesOn Sept. 11, 2023, U.S. Food and Drug Administration (FDA) authorized for emergency use new, updated (2023–2024) COVID-19 vaccines from Moderna and Pfizer. FDA deauthorized previous bivalent COVID-19 vaccines. On Sept. 11, 2023, FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC recommends new, updated (2023–2024) COVID-19 vaccines. CDC’s new, updated (2023–2014) COVID-19…